ATP competitive JNK inhibitor AS601245 reduced microglial activity, IgG extravasation, activation of caspase-3 pathway in endothelial cells and oligodendrocyte progenitors and attenuated perivascular aggregation of p-JNK-positive cells 24 h after stroke [54] (Figure 2). This evidence concerns the gene MAPK8 and stroke disorder.